Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 17

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  chemokine receptor
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Central nervous system and peripheral expression of CCL19, CCL21 and their receptor CCR7 in experimental model of multiple sclerosis

100%
Bielecki B., Jatczak-Pawlik I., Wolinski P., Bednarek A., Glabinski A.
Archivum Immunologiae et Therapiae Experimentalis
|
2015
|
tom 63
|
nr 5
2

SDF-1/CXCR4 axis promotes osteogenic differentiation of BMSCs through the JAK2/STAT3 pathway

100%
Xiong W., Guo X., Cai X.
Folia Histochemica et Cytobiologica
|
2021
|
tom 59
|
nr 3
3

Biological significance of chemokine receptor expression by normal human megakaryoblasts

100%
Majka M., Ratajczak J., Baj-Krzyworzeka M., Kijowski J., Reca R., Machalinski B., Kubiczek K., Ratajczak M. Z.
Folia Histochemica et Cytobiologica
|
2001
|
tom 39
|
nr 3
4

CXCR4-SDF-1 axis in metastasis of rhabdomyosarcomas

100%
Drukala J., Kucia M., Libura J., Ratajczak M. Z.
Cellular and Molecular Biology Letters
|
2002
|
tom 07
|
nr Suppl.
5

A burgeoning family of biological mediators: chemokines and chemokine receptors

100%
Le Y., Gong W., Shen W., Li B., Dunlop N. M., Wang J. M.
Archivum Immunologiae et Therapiae Experimentalis
|
2000
|
tom 48
|
nr 3
6

Analysis of recombinant Duffy protein-linked N-glycans using lectins and glycosidases

84%
Grodecka M., Czerwinski M., Duk M., Lisowska E., Wasniowska K.
Acta Biochimica Polonica
|
2010
|
tom 57
|
nr 1
49-53
 Duffy antigen is a glycosylated blood group protein acting as a malarial and chemokine receptor. Using glycosylation mutants we have previously demonstrated, that all three potential glycosylation sites of the Duffy antigen are occupied by N-linked oligosaccharide chains. In this study, wild-type Duffy glycoprotein and three mutants, each containing a single N-glycan, were used to characterize the oligosaccharide chains by lectin blotting and endoglycosidase digestion. The positive reaction of all the recombinant Duffy forms with Datura stramonium and Sambucus nigra lectins showed that each Duffy N-linked glycan contains Galβ1-4GlcNAc units terminated by (α2-6)-linked sialic acid residues, typical of complex oligosaccharides. The reactivity with Aleuria aurantia and Lens culinaris lectins suggested the presence of (α1-6)-linked fucose at the N-glycan chitobiose core. The failure of the Galanthus nivalis and Canavalia ensiformis lectins to bind to any of the Duffy mutants or to the wild-type antigen indicated that none of the three Duffy N-glycosylation sites carries detectable levels of high-mannose oligosaccharide chains. Digestion of Duffy samples with peptide N-glycosidase F and endoglycosidase H confirmed the presence of N-linked complex oligosaccharides. Our results indicate that Duffy antigen N-glycans are mostly core-fucosylated complex type oligosaccharides rich in N-acetyllactosamine and terminated by (α2-6)-linked sialic acid residues.
7

T cell chemokine receptor expression in human Th1- and Th2-associated diseases

84%
Campbell J. D., HayGlass K. T.
Archivum Immunologiae et Therapiae Experimentalis
|
2000
|
tom 48
|
nr 6 Spec.Iss.
451-456
8

In vitro immunological effects of CXCR3 inhibitor AMG487 on dendritic cells

84%
Qin C., Liu H., Tang B., Cao M., Yu Z., Liu B., Liu W., Dong Y., Ren H.
Archivum Immunologiae et Therapiae Experimentalis
|
2020
|
tom 68
|
nr 2
9

Naringenin promotes SDF-1/CXCR4 signaling pathway in BMSCs osteogenic differentiation

84%
Wang Y., Bai S., Cheng Q., Zeng Y., Xu X., Guan G.
Folia Histochemica et Cytobiologica
|
2021
|
tom 59
|
nr 1
10

Regulation of atherogenesis by chemokines and chemokine receptors

67%
Wan W., Murphy P. M.
Archivum Immunologiae et Therapiae Experimentalis
|
2013
|
tom 61
|
nr 1
11

The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking

67%
Kiss D. L., Longden J., Fechner G. A., Avery V. M.
Cellular and Molecular Biology Letters
|
2009
|
tom 14
|
nr 4
537-547
CC chemokine receptor 5 (CCR5) is a pro-inflammatory chemokine receptor that is expressed on cells of the immune system, and specializes in cell migration in response to inflammation and tissue damage. Due to its key role in cell communication and migration, this receptor is involved in various inflammatory and autoimmune diseases, in addition to HIV infection. Met-RANTES is a modified CCR5 ligand that has previously been shown to antagonize CCR5 activation and function in response to its natural ligands in vitro. In vivo, Met-RANTES is able to reduce inflammation in models of induced inflammatory and autoimmune diseases. However, due to the fact that Met-RANTES is also capable of partial agonist activity regarding receptor signaling and internalization, it is clear that Met-RANTES does not function as a conventional receptor antagonist. To further elucidate the effect of Met-RANTES on CCR5, receptor trafficking was investigated in a CHO-CCR5-GFP cell line using the Opera confocal plate reader. The internalization response of CCR5 was quantified, and showed that Met-RANTES internalized CCR5 in a slower, less potent manner than the agonists CCL3 and CCL5. Fluorescent organelle labeling and live cell imaging showed CCL3 and CCL5 caused CCR5 to traffic through sorting endosomes, recycling endosomes and the Golgi apparatus. In contrast, Met-RANTES caused CCR5 to traffic through sorting endosomes and the Golgi apparatus in a manner that was independent of recycling endosomes. As receptor trafficking impacts on cell surface expression and the ability of the receptor to respond to more ligand, this information may indicate an alternative regulation of CCR5 by Met-RANTES that allows the modified ligand to reduce inflammation through stimulation of a pro-inflammatory receptor.
12

Targeting novel antigens in the arterial wall in thromboangiitis obliterans

67%
Guzel E., Topal E., Yildirim A., Atilla P., Akkus M., Dagdeviren A.
Folia Histochemica et Cytobiologica
|
2010
|
tom 48
|
nr 1
134-141
13

Expanding diversity and common goal of regulatory T and B cells. II: in allergy, malignancy, and transplantation

67%
Korczak-Kowalska G., Stelmaszczyk-Emmel A., Bocian K., Kiernozek E., Drela N., Domagala-Kulawik J.
Archivum Immunologiae et Therapiae Experimentalis
|
2017
|
tom 65
|
nr 6
14

Biological activity of dendritic cells generated from cord blood CD34plus hematopoietic progenitors in IL-7- and IL-13-conditioned cultures

67%
Mytar B., Stec M., Weglarczyk K., Zembala M.
Archivum Immunologiae et Therapiae Experimentalis
|
2009
|
tom 57
|
nr 1
67-74
15
Content available remote

The role of oligodendrocytes in chronic pain: cellular and molecular mechanisms

67%
Malta I., Moraes T., Rodrigues G., Franco P., Galdino G.
Journal of Physiology and Pharmacology
|
2019
|
tom 70
|
nr 5
16

The immunological effects of interleukin 2 therapy in HIVplus patients

67%
De Paoli P.
Archivum Immunologiae et Therapiae Experimentalis
|
2000
|
tom 48
|
nr 4
17

Gender specific differences in the immune response to infection

59%
McClelland E. E., Smith J. M.
Archivum Immunologiae et Therapiae Experimentalis
|
2011
|
tom 59
|
nr 3
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.